Patrick R. O'Neil, EVP CLO & General Counsel at IONIS PHARMACEUTICALS INC (IONS), sold 12,900 shares at $51.75 ($668K) on 2024-01-25, disclosed to the SEC on 2024-01-29.
Scheduled sale ($668k) by EVP CLO & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.75 | 6,450 | $334K | 50.0% |
| 2 | $51.75 | 6,450 | $334K | 50.0% |
| Total | $51.75 avg | 12,900 | $668K | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $697K | — | Filing → |
| IONS | SELL | 2025-10-08 | $1.2M | — | Filing → |